By writer to www.prnewswire.com
About TransMedics Group, Inc.
TransMedics is the world’s chief in transportable extracorporeal heat perfusion and evaluation of donor organs for transplantation. Headquartered in Andover, Massachusetts, the corporate was based to deal with the unmet want for extra and higher organs for transplantation and has developed applied sciences to protect organ high quality, assess organ viability previous to transplant, and probably improve the utilization of donor organs for the therapy of end-stage coronary heart, lung, and liver failure.
This press launch accommodates forward-looking statements with respect to, the anticipated timing of the Advisory Committee assembly to assessment TransMedics’ premarket approval software for its OCS Liver and chance of regulatory approval. These forward-looking statements are topic to numerous dangers, uncertainties and assumptions. Furthermore, we function in a really aggressive and quickly altering surroundings and new dangers emerge once in a while. It’s not doable for our administration to foretell all dangers, nor can we assess the impression of all elements on our enterprise or the extent to which any issue, or mixture of things, might trigger precise outcomes to vary materially from these contained in or implied by any forward-looking statements we might make. In gentle of those dangers, uncertainties and assumptions, the forward-looking occasions and circumstances mentioned on this press launch might not happen and precise outcomes might differ materially and adversely from these anticipated or implied within the forward-looking statements. A few of the key elements that might trigger precise outcomes to vary embody: the timing of and our capacity to acquire and keep regulatory approvals or clearances for our OCS merchandise; our capacity to adequately reply to FDA follow-up inquiries in a well timed method; the timing or outcomes of medical trials for the OCS; regulatory developments in the US, European Union and different jurisdictions; and the dangers recognized underneath the heading “Threat Elements” in our Annual Report on Type 10-Ok for the 12 months ended December 31, 2020, which is offered on the SEC’s web site at www.sec.gov. Further data shall be made accessible by our annual and quarterly stories and different filings that we make once in a while with the SEC. These forward-looking statements converse solely as of the date of this press launch. Elements or occasions that might trigger our precise outcomes to vary might emerge once in a while, and it isn’t doable for us to foretell all of them. We undertake no obligation to replace any forward-looking assertion, whether or not on account of new data, future developments or in any other case, besides as could also be required by relevant legislation.
SOURCE TransMedics Group, Inc.
— to www.prnewswire.com